Objective: To evaluate the efficacy and safety of mirtazapine in the treatment of cardiovascular neurosis with depression.
目的：评价米氮平治疗伴抑郁的心血管神经症的临床疗效和安全性。
Conclusion: Mirtazapine is safe and effective in the treatment of cardiovascular neurosis with depression, and its effect appears earlier than that of fluoxetine.
结论：米氮平治疗伴抑郁的心血管神经症有效而安全，且起效时间早于氟西汀。
Objective To observe the depression ameliorated using Tongxinluo capsule in patients with cardiovascular neurosis and its mechanisms.
目的观察通心络胶囊能否改善心血管神经官能症患者的抑郁状态，并探讨其作用机理。
应用推荐